Restriction of HIV-1 infectivity by interferon and IFITM3 is counteracted by Nef
The viral accessory protein Nef is a major determinant of HIV-1 pathogenicity in vivo. Nef is a multifunctional, immunomodulatory protein that downmodulates cell surface proteins, including CD4 and MHC class I (MHC-I), which are important for T cell-mediated immunity. In addition, Nef also regulates cell-intrinsic immunity-Nef boosts the infectivity of virions produced and released from HIV-infected cells, at least in part, by counteracting the antiviral activity of transmembrane proteins SERINC3 and SERINC5. Here, we show that Nef proteins derived from many primary isolates of HIV-1 restore infectivity in interferon-treated cells and confer resistance to the antiviral protein interferon-induced transmembrane protein 3 (IFITM3) in a SERINC3/5-independent manner. Using Nef derived from primary HIV-1 clade C infection, we found that Nef interacts with IFITM3 in membranes, reduces IFITM3 incorporation into HIV-1 virions, and restores HIV-1 fusion with target cells. Our findings reveal a previously unrecognized immunomodulatory role for Nef in the setting of the interferon-induced antiviral state during HIV-1 infection.
Authors
- Mary K. Lewinski (ORCID: https://orcid.org/0000-0002-3784-9660)
- Mahesh Agarwal (ORCID: https://orcid.org/0009-0003-1988-1629)
- Alex A. Compton (ORCID: https://orcid.org/0000-0002-7508-4953)
- Kin Kui Lai (ORCID: https://orcid.org/0000-0003-2694-6243)
- Abigail A. Jolley (ORCID: https://orcid.org/0000-0002-4709-4919)
- Saliha Majdoul (ORCID: https://orcid.org/0000-0002-0530-6354)
- Isaiah Wilt
Institutions
- University of California San Diego (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- Science Advances
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1126/sciadv.adz7083
- Citations
- 2
- Primary Topic
- Viral Infections and Vectors
- Type
- article
- Field-Weighted Citation Impact
- 2.79